Co-Founder & CEO Isanans Pharma, & Advisor, Translution Capital
Kamilla Rolsted, PhD, MBA, is a life science executive with 20+ years of industry experience. Currently, she is Sr. Exec. Consultant at The Faculty of Health and Medical Sciences/UCPH focusing on innovation and entrepreneurship. She is also advising Nordic listed and non-listed biotech companies in equity-based fund raisings as part of Translution Capital, and finally, she is the co-founder of Isanans Pharma, a biotech company focusing on ophthalmology. Kamilla Rolsted previously held executive management/consultancy positions in different listed European biotech companies such as Zealand Pharma A/S, Akari Therapeutics and Bionor Pharma ASA with responsibility for strategy and business development and she has been involved in securing an aggregate of more than $120M in dilutive and non-dilutive funding.
Kamilla Rolsted serves on the Boards of The Pharmaceutical Society of Denmark and Pharmacists without Borders, Denmark.
Kamilla Rolsted is a certified pharmacist, has a PhD in bioanalysis/DMPK from University of Copenhagen and an executive MBA from Copenhagen Business School.